Correlation of Vaccine Responses.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 27 12 2020
accepted: 05 03 2021
entrez: 19 4 2021
pubmed: 20 4 2021
medline: 28 9 2021
Statut: epublish

Résumé

The humoral response to vaccinations varies widely between individuals. There is no data available on the correlation between responses to different vaccines. In this study, we investigated the correlation of antibody responses between routine vaccine antigens in infants. One and seven months after the 6-month vaccinations and one month after the 12-month vaccinations, antibody concentrations to diphtheria, tetanus, pertussis, polio (serotypes 1-3), The correlation between concentrations of antibodies to the vaccinations ending at 6 months of age was higher one month compared to seven months after vaccination. The strongest correlations at both time points were observed between antibody responses to different polio serotypes, certain pneumococcal serotypes and between responses to diphtheria and pneumococcal (conjugated to a diphtheria toxoid) vaccine antigens. Correlation between responses to tetanus, Hib, pertussis, polio and other vaccine antigens were weak. The correlation between antibody responses to the 12-month vaccine antigens was weaker than to the 6-month vaccine antigens and there was a negative correlation between responses to measles, mumps, rubella vaccine and non-live vaccine antigens (meningococcus C, tetanus and Hib). There was only weak correlation between antibody responses to vaccines of the same type (e.g. conjugated polysaccharide or toxoid vaccines). Correlation between antibody responses to similar antigens in the same vaccine (such as different serotypes of a bacteria or virus), as well as responses to antigens conjugated to similar carrier proteins, are strong. In contrast, correlation between responses to other vaccines are weak. Measuring antibody responses to one or a few vaccine antigens therefore does not offer a reliable surrogate marker of responses to unrelated vaccines.

Identifiants

pubmed: 33868282
doi: 10.3389/fimmu.2021.646677
pmc: PMC8050335
doi:

Substances chimiques

Antibodies, Bacterial 0
Antibodies, Viral 0
Bacterial Vaccines 0
Diphtheria-Tetanus-acellular Pertussis Vaccines 0
Haemophilus Vaccines 0
Hepatitis B Vaccines 0
Pertussis Vaccine 0
Pneumococcal Vaccines 0
Viral Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

646677

Informations de copyright

Copyright © 2021 Zimmermann, Ritz, Perrett, Messina, van der Klis and Curtis.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Vaccine. 2016 Aug 5;34(36):4278-84
pubmed: 27423382
Clin Microbiol Rev. 2019 Mar 13;32(2):
pubmed: 30867162
Clin Vaccine Immunol. 2012 Mar;19(3):396-400
pubmed: 22237896
Pediatr Infect Dis J. 2006 Apr;25(4):306-11
pubmed: 16567981
Clin Vaccine Immunol. 2009 Mar;16(3):433-6
pubmed: 19129470
J Infect Dis. 2012 May 1;205(9):1408-16
pubmed: 22457293
J Allergy Clin Immunol. 2012 Sep;130(3 Suppl):S1-24
pubmed: 22935624
Vaccine. 2018 Jan 25;36(4):473-478
pubmed: 29248266
J Immunol Methods. 2008 Jun 1;335(1-2):79-89
pubmed: 18407287
J Virol Methods. 2017 Mar;241:15-23
pubmed: 27988324
Clin Vaccine Immunol. 2008 Aug;15(8):1188-93
pubmed: 18550729
Immunol Cell Biol. 2019 Jul;97(6):577-585
pubmed: 30791143
Clin Vaccine Immunol. 2010 Apr;17(4):674-82
pubmed: 20130129
Pediatr Infect Dis J. 2012 Aug;31(8):e133-40
pubmed: 22622699

Auteurs

Petra Zimmermann (P)

Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Murdoch Children's Research Institute, Parkville, VIC, Australia.

Nicole Ritz (N)

University of Basel, Basel, Switzerland.
The University of Melbourne, Parkville, VIC, Australia.

Kirsten P Perrett (KP)

Murdoch Children's Research Institute, Parkville, VIC, Australia.
The University of Melbourne, Parkville, VIC, Australia.
Royal Children's Hospital Melbourne, Parkville, VIC, Australia.

Nicole L Messina (NL)

Murdoch Children's Research Institute, Parkville, VIC, Australia.
The University of Melbourne, Parkville, VIC, Australia.

Fiona R M van der Klis (FRM)

National Institute for Public Health and the Environment, Bilthoven, Netherlands.

Nigel Curtis (N)

Murdoch Children's Research Institute, Parkville, VIC, Australia.
The University of Melbourne, Parkville, VIC, Australia.
Royal Children's Hospital Melbourne, Parkville, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH